Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000708080 | SCV000837190 | pathogenic | Tuberous sclerosis 2 | 2018-05-25 | criteria provided, single submitter | clinical testing | This variant results in a copy number gain of the genomic region encompassing exons 3-16 of the TSC2 gene. While the exact position of this variant cannot be determined from this data, sub-genic copy number gains are generally in tandem (PMID: 25640679). This variant would be expected to be in-frame, preserving the integrity of the reading frame. This variant has been observed to be de novo in an individual with clinical features of tuberous sclerosis complex (Invitae). Experimental studies and prediction algorithms are not available for this variant, and the functional significance of the duplicated amino acids is currently unknown. For these reasons, this variant has been classified as Pathogenic. |